We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Potential of Gene Therapy for Treating Hemophilia Demonstrated in Dog Model

By LabMedica International staff writers
Posted on 02 Feb 2016
Print article
Image: Molecular model of coagulation Factor VII (Photo courtesy of Wikimedia Commons).
Image: Molecular model of coagulation Factor VII (Photo courtesy of Wikimedia Commons).
A gene therapy approach was shown to cure a form of hemophilia caused by deficiency of the Factor VII coagulation protein in a dog model system.

Factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder treated by infusion of fresh-frozen plasma, plasma-derived FVII concentrates, and low-dose recombinant activated FVII. Clinical data have suggested that a mild elevation of plasma FVII levels results in improved clotting behavior.

Research dogs with a G96E missense FVII mutation (FVII-G96E) have less than 1% of normal FVII activity. Investigators at the University of North Carolina (Chapel Hill, USA) and The Children’s Hospital of Philadelphia (PA, USA) used the Western blot technique to show that these dogs had undetectable plasmatic antigen, and thus represented the most prevalent type of human FVII deficiency (low antigen/activity).

The investigators treated these animals by gene therapy using liver-directed, Adeno-associated viral (AAV) serotype VIII vector delivery of a canine FVII zymogen transgene (cFVII). The group of four dogs received escalating AAV doses.

Results published in the December 23, 2015, online edition of the journal Blood revealed that therapeutic expression of the gene (15% of normal) was attained and was stable for more than one year (ongoing) without antibody formation to the cFVII transgene. A level of gene expression more that 770% of normal was found in the dog receiving the highest AAV dose.

No evidence of pathological activation of coagulation or detrimental animal physiology was observed as platelet counts, D-dimer, fibrinogen levels, and serum chemistries remained normal in all dogs (cumulative 6.4 years). A transient and non-inhibitory IgG2 response against cFVII was seen only in the dog receiving the highest AAV dose.

“For many people living in the developing world, constant injections are not practical or at least not feasible right now; but a single injection could be,” said contributing author Dr. Tim Nichols, professor of medicine and pathology at the University of North Carolina. “We have now shown that this treatment is safe and effective for dogs with inherited factor VII deficiency. This is exciting because our other gene therapy work on bleeding disorders, such as hemophilia, has demonstrated that safety and efficacy in dogs has translated well in human clinical trials.”

Related Links:

University of North Carolina
The Children’s Hospital of Philadelphia


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.